Evidence map›Paper›PMID 33469456›Full record

ArticleFrontiers in immunology2020

Regulation of Decay Accelerating Factor Primes Human Germinal Center B Cells for Phagocytosis.

Andy Dernstedt, Jana Leidig, Anna Holm, Priscilla F Kerkman, Jenny Mjösberg, Clas Ahlm, Johan Henriksson, Magnus Hultdin, Mattias N E Forsell

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Frontiers in immunology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT07346820 (VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation, an Observational Study), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
0.9field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT07346820 not yet recruitingnot on this mapstarted 2026, after this paper: background citation

VDJ-recombination of the B-cell Receptor Following Hematopoietic Stem Cell Transplantation, an Observational Study

TypeobservationalSponsorUmeå UniversityRan2026 to 2036Enrolled65ConditionsStem Cell Transplantation, Hematopoietic, V(D)J Recombination, Receptors, Antigen, B-Cel
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Comprehensive phenotyping of human peripheral blood B lymphocytes in healthy conditions.Cytometry. Part A : the journal of the International Society for Analytical Cytology · 2022
    Review
  7. Article
  8. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 2 institutions in 1 country.

Andy DernstedtDepartment of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
Jana LeidigDepartment of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
Anna HolmDepartment of Clinical Sciences, Division of Otorhinolaryngology, Umeå University, Umeå, Sweden.
Priscilla F KerkmanDepartment of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
Jenny MjösbergCenter for Infectious Medicine, Department of Medicine, Karolinska Institutet, Stockholm, Sweden.
Clas AhlmDepartment of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
Johan HenrikssonMolecular Infection Medicine Sweden, Department of Molecular Biology, Umeå University, Umeå, Sweden.
Magnus HultdinDepartment of Medical Biosciences, Pathology, Umeå University, Umeå, Sweden.
Mattias N E ForsellDepartment of Clinical Microbiology, Section of Infection and Immunology, Umeå University, Umeå, Sweden.
Umeå University · SEKarolinska Institutet · SE

Funding

Prometheus: A Platform for Rapid Development of Human Antibody-based Therapeutics and Prophylactics against Emerging Viral ThreatsU19AI142777 · NIAID · ALBERT EINSTEIN COLLEGE OF MEDICINE · PI CHANDRAN, KARTIK · 2019 to 2023
$21.9M
NIAID NIH HHS U19 AI142777
6 · The paper itself

Abstract

Germinal centers (GC) are sites for extensive B cell proliferation and homeostasis is maintained by programmed cell death. The complement regulatory protein Decay Accelerating Factor (DAF) blocks complement deposition on host cells and therefore also phagocytosis of cells. Here, we show that B cells downregulate DAF upon BCR engagement and that T cell-dependent stimuli preferentially led to activation of DAF

Indexed as

Lymphocyte ActivationPhagocytosisB-LymphocytesCD55 AntigensGene Expression RegulationGerminal CenterHumansPositive Regulatory Domain I-Binding Factor 1CD55 AntigensPositive Regulatory Domain I-Binding Factor 1PRDM1 protein, humancomplement-mediated phagocytosiscomplement regulating proteinsdecay accelerating factor (DAF)germinal center (GC)human B cell development

Identifiers

PMID33469456
PMCPMC7813799
OpenAlexW3119099693

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.